相似文献
1
Transforming Growth Factor β Superfamily Signaling in Development of Colorectal Cancer.
Gastroenterology. 2017 Jan;152(1):36-52. doi: 10.1053/j.gastro.2016.10.015. Epub 2016 Oct 20.
2
A road map toward defining the role of Smad signaling in hematopoietic stem cells.
Stem Cells. 2006 Apr;24(4):1128-36. doi: 10.1634/stemcells.2005-0263. Epub 2005 Dec 15.
3
Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.
Mol Endocrinol. 2004 Mar;18(3):653-65. doi: 10.1210/me.2003-0393. Epub 2003 Dec 18.
4
Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
Gastroenterology. 2017 Nov;153(5):1378-1391.e6. doi: 10.1053/j.gastro.2017.07.014. Epub 2017 Jul 20.
5
Tgf-beta superfamily and mouse craniofacial development: interplay of morphogenetic proteins and receptor signaling controls normal formation of the face.
Curr Top Dev Biol. 2005;66:65-133. doi: 10.1016/S0070-2153(05)66003-6.
6
Tgf-beta signaling alterations and colon cancer.
Cancer Treat Res. 2010;155:85-103. doi: 10.1007/978-1-4419-6033-7_5.
7
SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7.
Mol Pharmacol. 2002 Jul;62(1):65-74. doi: 10.1124/mol.62.1.65.
8
TGF-beta signaling alterations and susceptibility to colorectal cancer.
Hum Mol Genet. 2007 Apr 15;16 Spec No 1(SPEC):R14-20. doi: 10.1093/hmg/ddl486.
9
TGF-β family co-receptor function and signaling.
Acta Biochim Biophys Sin (Shanghai). 2018 Jan 1;50(1):12-36. doi: 10.1093/abbs/gmx126.
10
Expression of TGF-beta superfamily growth factors, their receptors, the associated SMADs and antagonists in five isolated size-matched populations of pre-antral follicles from normal human ovaries.
Mol Hum Reprod. 2014 Apr;20(4):293-308. doi: 10.1093/molehr/gat089. Epub 2013 Nov 22.
引用本文的文献
1
Development and validation of a novel risk stratification signature derived from migrasome and tumor microenvironment-related genes for molecular subtyping and improving clinical outcomes in head and neck squamous cell carcinoma.
Ann Med. 2025 Dec;57(1):2558121. doi: 10.1080/07853890.2025.2558121. Epub 2025 Sep 9.
2
Role of exosomes in transforming growth factor-β-mediated cancer cell plasticity and drug resistance.
Explor Target Antitumor Ther. 2025 Jun 5;6:1002322. doi: 10.37349/etat.2025.1002322. eCollection 2025.
3
Prkci promotes colorectal cancer metastasis by phosphorylating and stabilizing Tgfbr1 to activate TGF-β signaling.
Cell Commun Signal. 2025 May 17;23(1):230. doi: 10.1186/s12964-025-02236-6.
4
Advances in Targeted and Chemotherapeutic Strategies for Colorectal Cancer: Current Insights and Future Directions.
Biomedicines. 2025 Mar 5;13(3):642. doi: 10.3390/biomedicines13030642.
5
Single-cell and spatial transcriptomic analysis reveals tumor cell heterogeneity and underlying molecular program in colorectal cancer.
Front Immunol. 2025 Mar 12;16:1556386. doi: 10.3389/fimmu.2025.1556386. eCollection 2025.
6
Nanomedicine innovations in colon and rectal cancer: advances in targeted drug and gene delivery systems.
Med Oncol. 2025 Mar 17;42(4):113. doi: 10.1007/s12032-025-02670-z.
7
Inflammation in cancer: therapeutic opportunities from new insights.
Mol Cancer. 2025 Feb 24;24(1):51. doi: 10.1186/s12943-025-02243-8.
8
Molecular and functional profiling unravels targetable vulnerabilities in colorectal cancer.
Mol Oncol. 2025 Jun;19(6):1751-1774. doi: 10.1002/1878-0261.13814. Epub 2025 Jan 28.
9
The plasticity of epithelial cells and its potential in the induced differentiation of gastric cancer.
Cell Death Discov. 2024 Dec 24;10(1):512. doi: 10.1038/s41420-024-02275-x.
10
Clinical and genetic drivers of oligo-metastatic disease in colon cancer.
Neoplasia. 2025 Feb;60:101111. doi: 10.1016/j.neo.2024.101111. Epub 2024 Dec 21.
本文引用的文献
1
Loss of TGFβ signaling promotes colon cancer progression and tumor-associated inflammation.
Oncotarget. 2017 Jan 17;8(3):3826-3839. doi: 10.18632/oncotarget.9830.
2
TGFβ signaling directs serrated adenomas to the mesenchymal colorectal cancer subtype.
EMBO Mol Med. 2016 Jul 1;8(7):745-60. doi: 10.15252/emmm.201606184. Print 2016 Jul.
3
Activin B Induces Noncanonical SMAD1/5/8 Signaling via BMP Type I Receptors in Hepatocytes: Evidence for a Role in Hepcidin Induction by Inflammation in Male Mice.
Endocrinology. 2016 Mar;157(3):1146-62. doi: 10.1210/en.2015-1747. Epub 2016 Jan 6.
4
TGF-β signalopathies as a paradigm for translational medicine.
Eur J Med Genet. 2015 Dec;58(12):695-703. doi: 10.1016/j.ejmg.2015.10.010. Epub 2015 Oct 24.
5
Activin and TGFβ use diverging mitogenic signaling in advanced colon cancer.
Mol Cancer. 2015 Oct 24;14:182. doi: 10.1186/s12943-015-0456-4.
6
The consensus molecular subtypes of colorectal cancer.
Nat Med. 2015 Nov;21(11):1350-6. doi: 10.1038/nm.3967. Epub 2015 Oct 12.
7
Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS.
Gastroenterology. 2016 Jan;150(1):218-228.e12. doi: 10.1053/j.gastro.2015.09.013. Epub 2015 Sep 25.
8
Signaling in Fibrosis: TGF-β, WNT, and YAP/TAZ Converge.
Front Med (Lausanne). 2015 Sep 3;2:59. doi: 10.3389/fmed.2015.00059. eCollection 2015.
9
Sotatercept (ACE-011) for the treatment of chemotherapy-induced anemia in patients with metastatic breast cancer or advanced or metastatic solid tumors treated with platinum-based chemotherapeutic regimens: results from two phase 2 studies.
Support Care Cancer. 2016 Apr;24(4):1517-25. doi: 10.1007/s00520-015-2929-9. Epub 2015 Sep 14.
10
Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway.
Drug Des Devel Ther. 2015 Aug 10;9:4479-99. doi: 10.2147/DDDT.S86621. eCollection 2015.
Zotero 插件